| Ketamine for Opioid Use Disorder (NCT06943859) | University of Maryland, Baltimore | 2026-02-04 |
| IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer (NCT07402070) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-02-04 |
| Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). (NCT07471789) | Gyala Therapeutics | 2026-02-04 |
| De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients (NCT06557421) | Institut Paoli-Calmettes | 2026-02-04 |
| Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) (NCT07480954) | Beijing Biotech | 2026-02-04 |
| Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair (NCT07226791) | AbbVie | 2026-02-04 |
| Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis: A Randomized Double-Blind Placebo-Controlled Trial (NCT07715045) | Universitas Sriwijaya | 2026-02-04 |
| Efficacy of Rifaximin With NAC in IBS-D (NCT06727422) | Mark Pimentel, MD | 2026-02-04 |
| INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes (NCT07224321) | Mannkind Corporation | 2026-02-04 |
| A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. (NCT06797986) | Cellid Co., Ltd. | 2026-02-04 |
| A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease (NCT07399704) | Azafaros B.V. | 2026-02-04 |
| Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes (NCT07228624) | Fred Hutchinson Cancer Center | 2026-02-04 |
| PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC (NCT07332247) | Sun Yat-sen University | 2026-02-03 |
| Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia (NCT06761560) | Yves Pastore | 2026-02-03 |
| Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT) (NCT07227610) | Medical University of South Carolina | 2026-02-03 |
| Modulation of Cerebral Ischemia by Albumin (NCT07415655) | University Hospital Hradec Kralove | 2026-02-03 |
| A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer (NCT07325136) | Bristol-Myers Squibb | 2026-02-03 |
| A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis (NCT07193589) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-02-03 |
| A Study for HSK47388 in Participants With Ulcerative Colitis (NCT07335055) | Haisco Pharmaceutical Group Co., Ltd. | 2026-02-03 |
| Evaluate RLS-1496 Topical Cream for Actinic Keratosis (NCT07340697) | Rubedo Life Sciences, Inc. | 2026-02-03 |
| Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) (NCT07357519) | Lantheus Medical Imaging | 2026-02-03 |
| A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC (NCT07264816) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-02-03 |
| A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia (NCT07400029) | Memorial Sloan Kettering Cancer Center | 2026-02-03 |
| Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study (NCT06923787) | Institute of Oncology Ljubljana | 2026-02-03 |
| CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL (NCT07397832) | Tianjin Medical University Cancer Institute and Hospital | 2026-02-03 |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder (NCT06696755) | AbbVie | 2026-02-03 |
| Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty (NCT07214311) | Peptilogics | 2026-02-03 |
| Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease (NCT07363265) | Longbio Pharma | 2026-02-02 |
| Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) (NCT07480213) | Beijing Biotech | 2026-02-02 |
| Y-4 to Treat the Postherpetic Neuralgia (NCT07275762) | Neurodawn Pharmaceutical Co., Ltd. | 2026-02-02 |
| Safety and Efficacy of Topical AT-004 1% in Participants With Acne Vulgaris (AV) (NCT07774364) | Arctic Therapeutics | 2026-02-02 |
| Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer (NCT07589517) | Beijing Biotech | 2026-02-02 |
| TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) (NCT07355257) | Zhongming Qiu | 2026-02-02 |
| Topical GHK-Cu Gel for Acute Skin Wound Healing (NCT07437586) | Hudson Biotech | 2026-02-02 |
| Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa (NCT07213973) | Incyte Corporation | 2026-02-02 |
| Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM. (NCT07638852) | Fudan University | 2026-02-02 |
| A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension (NCT07425262) | Chang Gung Memorial Hospital | 2026-02-02 |
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo (NCT07437560) | Hudson Biotech | 2026-02-02 |
| Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk (NCT07007208) | University Hospital, Toulouse | 2026-02-02 |
| Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) (NCT07481734) | Hudson Biotech | 2026-02-02 |
| A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax (NCT07148180) | Jacqueline Garcia, MD | 2026-02-02 |
| Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor (NCT07331792) | Combined Military Hospital Abbottabad | 2026-02-02 |
| Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS (NCT07413094) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2026-02-02 |
| A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity (NCT07395687) | Novo Nordisk A/S | 2026-02-02 |
| Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) (NCT07224360) | CSL Behring | 2026-02-02 |
| Minocycline in Stroke Study at Maimonides (NCT07237048) | Joyce Chen | 2026-02-02 |
| Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer (NCT07393425) | Shanghai Jiao Tong University School of Medicine | 2026-02-02 |
| A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease (NCT07157735) | Cambridge University Hospitals NHS Foundation Trust | 2026-02-02 |
| Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma (NCT07551349) | Beijing Biotech | 2026-02-02 |
| Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia (NCT07284472) | Exciva GmbH | 2026-02-02 |
| Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer (NCT07325721) | Medical University of South Carolina | 2026-02-02 |
| A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis (NCT06968845) | Rein Therapeutics | 2026-02-02 |
| Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC (NCT07467863) | Beijing Biotech | 2026-02-02 |
| Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC (NCT07510802) | Beijing Biotech | 2026-02-02 |
| Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) (NCT07486089) | Beijing Biotech | 2026-02-02 |
| Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma (NCT07480928) | Beijing Biotech | 2026-02-02 |
| A Study of GR1803 in Systemic Lupus Erythematosus (NCT07348055) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2026-02-02 |
| MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity (NCT07505745) | Hudson Biotech | 2026-02-02 |
| BPC 157 for Acute Hamstring Muscle Strain Repair (NCT07437547) | Hudson Biotech | 2026-02-02 |
| Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis (NCT06913647) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2026-02-01 |
| ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse (NCT07379203) | Wits Health Consortium (Pty) Ltd | 2026-02-01 |
| Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury (NCT06654193) | Hope Biosciences LLC | 2026-02-01 |
| Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections (NCT06428448) | OsteoRemedies, LLC | 2026-02-01 |
| Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients (NCT07370506) | Tanta University | 2026-02-01 |
| Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement (NCT07369089) | University of California, San Diego | 2026-02-01 |
| EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors (NCT07410676) | Essen Biotech | 2026-02-01 |
| PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma (NCT07207785) | Fondazione Italiana Linfomi - ETS | 2026-02-01 |
| Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial (NCT07295834) | Imperial College London | 2026-02-01 |
| Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer (NCT06849947) | Yeon Hee Park | 2026-02-01 |
| FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial (NCT06062888) | Northwestern University | 2026-02-01 |
| Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer (NCT07407452) | Jiangsu Cancer Institute & Hospital | 2026-02-01 |
| A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer. (NCT07307443) | Zhijie Wang | 2026-02-01 |
| A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07381075) | West China Hospital | 2026-02-01 |
| The Effect of Probiotics on Gut Microbiota Changes in Healthy Chinese Adults During Short-Term European Travel: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial (NCT07384260) | Min-Tze LIONG | 2026-02-01 |
| FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer (NCT07418866) | Fudan University | 2026-02-01 |
| Kamuvudine-9 (K9) in Diabetic Macular Edema (NCT07458061) | Dr. Bryan Strelow | 2026-02-01 |
| Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC (NCT07400094) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2026-02-01 |
| A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum (NCT07337564) | Shandong First Medical University | 2026-02-01 |
| Photo-Acoustic and Ultrasonographic Mammoscope (NCT07492589) | Franciscus Gasthuis & Vlietland (Hospital) | 2026-02-01 |
| Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma (NCT07347444) | Fudan University | 2026-02-01 |
| A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy (NCT07548060) | Tianjin Medical University Cancer Institute and Hospital | 2026-02-01 |
| Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study (NCT07398560) | The Third Affiliated Hospital of Harbin Medical University | 2026-02-01 |
| Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial. (NCT07421856) | Hebei Senlang Biotechnology Inc., Ltd. | 2026-02-01 |
| Dietary Interventions to Reduce Ultra-Processed Food Intake (NCT07226336) | Oregon Research Institute | 2026-02-01 |
| Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome (NCT07233330) | Mario Negri Institute for Pharmacological Research | 2026-02-01 |
| Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma (NCT07374250) | Sichuan University | 2026-02-01 |
| Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease (NCT07437625) | Li Min | 2026-02-01 |
| Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery (NCT07400302) | The First Hospital of Jilin University | 2026-02-01 |
| Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma (NCT07418190) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-01 |
| Soy Tomato Juice to Improve Outcomes in Pancreatitis (NCT07447687) | Ohio State University | 2026-02-01 |
| SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma (NCT07347288) | The First Affiliated Hospital with Nanjing Medical University | 2026-02-01 |
| Effect of Add-on L-Arginine Therapy on Heart Failure Patients (NCT07394270) | German University in Cairo | 2026-02-01 |
| A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma (NCT07389616) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2026-02-01 |
| A Study of VV-14305 for the Treatment of Thyroid Eye Disease (NCT07404111) | Kriya Therapeutics, Inc. | 2026-02-01 |
| Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients (NCT07338344) | Rongrong Liu | 2026-02-01 |
| A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond. (NCT07395063) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2026-02-01 |
| A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma (NCT07482059) | West China Hospital | 2026-02-01 |
| Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus (NCT06227221) | Second Xiangya Hospital of Central South University | 2026-02-01 |
| Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors (NCT07410494) | Essen Biotech | 2026-02-01 |
| LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer (NCT06831955) | Universitaire Ziekenhuizen KU Leuven | 2026-02-01 |